Surgical oophorectomy: a primary option in adjuvant treatment of premenopausal breast cancer
RR Love - Medical Research Archives, 2017 - esmed.org
Abstract Globally, there are 500,000 annual new cases of hormone-sensitive breast cancer
in premenopausal women; 400,000 of these occur in women in low and middle income …
in premenopausal women; 400,000 of these occur in women in low and middle income …
[PDF][PDF] Surgical Oophorectomy Plus Tamoxifen Provides the Optimal Systemic Treatment for Pre-Menopausal Women with Hormone Sensitive Breast Cancer
RR Love - J Surg, 2017 - pdfs.semanticscholar.org
Surgical oophorectomy should have a major place in treatment of pre-menopausal women
with hormone-receptor positive breast cancer. New data on increasing efficacy and multiple …
with hormone-receptor positive breast cancer. New data on increasing efficacy and multiple …
Adjuvant surgical oophorectomy plus tamoxifen in premenopausal women with operable hormone receptor–positive breast cancer: A global treatment option
RR Love - Clinical Breast Cancer, 2016 - Elsevier
One third of annual new cases of breast cancer globally are now hormone receptor–positive
tumors in premenopausal women from low-and middle-income countries. For this subgroup …
tumors in premenopausal women from low-and middle-income countries. For this subgroup …
Surgical oophorectomy for breast cancer: back to the future
RR Love, GB Uy - 2008 - Taylor & Francis
While the preponderance of current scientific presentations on breast cancer therapies has
focused on chemotherapeutic strategies, targeted therapy with tyrosine kinase inhibitors and …
focused on chemotherapeutic strategies, targeted therapy with tyrosine kinase inhibitors and …
[PDF][PDF] By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive …
R Love - Archives of Breast Cancer, 2021 - archbreastcancer.com
• Individual patient (in researchers' experiences) versus global public health treatment
paradigms, with limited consideration of the equity issues 14 associated with these …
paradigms, with limited consideration of the equity issues 14 associated with these …
[HTML][HTML] Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer
RR Love, GS Young, EM Hade, D Jarjoura - Breast cancer research and …, 2011 - Springer
Adjuvant surgical oophorectomy is an effective and remarkably cost effective treatment for
premenopausal women with hormone receptor positive operable breast cancer. Previously …
premenopausal women with hormone receptor positive operable breast cancer. Previously …
Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer
RR Love, NB Duc, DC Allred, NC Binh… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: In 1992, the Early Breast Cancer Trialists' Collaborative Group reported that a
meta-analysis of six randomized trials in European and North American women begun from …
meta-analysis of six randomized trials in European and North American women begun from …
Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women
RR Love, N Van Dinh, TT Quy, ND Linh… - Journal of clinical …, 2008 - ascopubs.org
Purpose Worldwide, approximately 750,000 new cases of breast cancer are diagnosed
annually in premenopausal women with limited economic resources. Longer-term survival …
annually in premenopausal women with limited economic resources. Longer-term survival …
[HTML][HTML] Oophorectomy in breast cancer—controversies and current status
G Singh - Indian Journal of Surgery, 2012 - Springer
The role of oophorectomy in the treatment of breast cancer is known for over 100 years.
Ovarian ablation has a relatively large positive effect on both disease-free survival (DFS) …
Ovarian ablation has a relatively large positive effect on both disease-free survival (DFS) …
Selection of optimal adjuvant endocrine therapy for early-stage breast cancer
A Al-Hajj, R O'Regan - Current Treatment Options in Oncology, 2006 - Springer
Opinion statement Oophorectomy was found to cause regression of advanced breast cancer
toward the end of the 19th century. Decades later, the discovery that estrogen plays a central …
toward the end of the 19th century. Decades later, the discovery that estrogen plays a central …
相关搜索
- breast cancer premenopausal women
- breast cancer treatment option
- breast cancer surgical oophorectomy
- treatment option premenopausal women
- breast cancer hormone receptor
- treatment option hormone receptor
- surgical oophorectomy adjuvant treatment
- primary option surgical oophorectomy
- primary option adjuvant treatment
- adjuvant oophorectomy premenopausal women
- breast cancer effects on survival
- breast cancer cycle phase
- breast cancer adjuvant treatment
- breast cancer adjuvant oophorectomy
- breast cancer primary option
- breast cancer premenopausal vietnamese